API
< Back to situation

[REVISION HISTORY]

Ghana pharmaceutical and manufacturing development

6 recorded revisions of this situation.

What changed

2026-11-09 11:53 UTC → 2026-11-10 13:14 UTC · added removed

Ghana is implementing strategic initiatives to bolster domestic manufacturing and reduce dependence on imported goods, with a particular focus on the healthcare sector. To address the fact that imports currently account for approximately 70% of the country’s medicine supply, with an annual import bill exceeding US$750 million, the government has launched the Ghana Pharmaceutical Manufacturing Policy (GPMP). Approved by Cabinet, this policy aims to increase the domestic market share of locally manufactured medicines from 30% to 60% within five years, moving toward a long-term goal of 70% pharmaceutical self-sufficiency. The government also intends to double pharmaceutical exports to the Economic Community of West African States (ECOWAS) markets. A central component of the GPMP is the creation of a pharmaceutical hub or park to consolidate manufacturers, research facilities, and input suppliers. Phase 2 of this plan, proposed for the Central Region, focuses on the production of active pharmaceutical ingredients (APIs), herbal medicines, and raw materials such as pharmaceutical-grade corn starch and ethyl alcohol. To support industrial growth, the Food and Drugs Authority (FDA) has introduced a new framework to guide investors. Under this pathway, investors must complete construction, equipment installation, and process validation before applying for a Good Manufacturing Practice (GMP) license. Dr. George Sabblah, Deputy CEO of the FDA, stated this aims to reduce regulatory uncertainty. Research projects are also advancing locally produced treatments through the PharmaVax Ghana initiative. The Centre for Plant Medicine Research is conducting clinical trials for URO 500, a herbal medicine for prostate health, while researchers also test the stability of a locally manufactured snake venom antiserum. Recent developments highlight the link between manufacturing and public health funding. Trade, Agribusiness and Industry Minister Elizabeth Ofosu-Adjare has emphasized the policy’s role in reducing the massive foreign exchange burden incurred by African nations for pharmaceutical imports.

Versions

  1. 2026-11-10 13:14 UTC Ghana pharmaceutical and manufacturing development
  2. 2026-11-09 11:53 UTC Ghana pharmaceutical and manufacturing development
  3. 2026-11-03 02:36 UTC Ghana pharmaceutical and manufacturing development
  4. 2026-11-02 06:08 UTC Ghana pharmaceutical and manufacturing development
  5. 2026-10-31 10:44 UTC Ghana pharmaceutical and manufacturing development
  6. 2026-10-29 22:15 UTC Ghana pharmaceutical and manufacturing development
  7. 2026-10-28 19:24 UTC Ghana pharmaceutical and manufacturing development

Select a version to see what changed compared to the one before it.